120% Delivery Masks the Capex Year Ahead
The quarter delivered exceptional growth and hit every operational target. But the balance sheet is burning working capital, debt is rising, and ₹168 crore in R&D capex lies ahead — the market has priced in the growth, not the financial headwinds.
₹296.7 Cr
+120% YoY
₹31.4 Cr
+164% YoY
13.6%
+160bps YoY
₹44.8 Cr
↑ from ₹25 Cr
0.31x
↑ from 0.18x
Zelio delivered a quarter that reads like a venture founder's dream: revenue up 120%, profit up 164%, every unit target on pace, all 400+ dealers profitable. The machine works. But the machinery is burning cash. Working capital swung negative in H1, borrowings jumped 80%, and the company has committed ₹168 crore over 2–3 years to R&D and backward integration — a bet that will shave 1–2% off EBITDA before it pays off. The growth is real. So is the capex bill.
Where the growth came from
This is a small base catching up. Full-year FY26 was roughly 70,000 units and ₹240 crore in revenue. H1 FY27 is 62,000+ units and ₹297 crore — a half-year nearly as large as the prior full year, which is why percentage growth looks like +120%. The low-speed segment (₹48–50k ASP, 50%+ of mix) is the workhorse; high-speed launches have barely moved the needle yet. Unit economics are holding: 62,000+ units in 6 months puts full-year FY27 at a 125,000-unit run-rate, exactly on management's guidance. Dealer count is 400–450 (target was 550 by end of year, now paused due to demand overwhelming capacity). Capacity is 312,000 units installed across 4 plants, so utilization is a loose 40–50% combined — intentional ramp, not under-demand.
120% revenue growth, hitting every target
296.7 Cr (vs ~135 prior H1), 62k units (vs 70k full FY26), dealer paused but on track to resume
Supported
On track for 125k units, 550 dealers, 75–80% FY27 growth
H1 delivery 62k (run-rate 124k), dealer count at 400–450 (paused due to supply constraint, not demand miss)
Supported
EBITDA margin up to 13.6%, holding profitability despite scale
13.6% = 40.49 Cr EBITDA ÷ 296.7 Cr revenue, up 160bps from 12% prior year
Supported
No competitors in low-speed segment
Zelio has 8–9% share; market is unorganized, smaller entrants arriving; Zelio first organized brand but not alone
Overstated (more accurate: 'first organized player')
Working capital under control, receivables <6 days
OCF negative in H1, borrowings up to ₹44.8 Cr, inventory buildup for 4-plant ramp, debt/equity 0.31x rising
Partial (receivables tight, but payables loaded for seasonal demand)
What changed on this call
Dealer network: paused, then resume. Prior call pushed for 550 dealers by end of year. This quarter: stuck at 400–450 because demand surge overwhelmed existing dealer capacity. Management paused new additions to fulfil existing orders, plans to resume H2 FY27 once capex eases. Strategy upgrade to R&D. Announced ₹168 crore capital raise explicitly for R&D (motors, batteries, power training), not capacity. Signals shift from volume-driven expansion to tech self-reliance. Motors and batteries to be developed in-house within 2–3 years. Market share timeline extended. Prior guidance: 20–30% EV two-wheeler share in 2–3 years (by 2027–28). New: 25% share by 2030 (10-year horizon). Same number, later target = slower pace, suggesting more cautious long-term view despite near-term strength. Capex impact on margins quantified. R&D will hit EBITDA by 1–2%, but management believes capacity leverage offsets in full-year. This is the key forecast risk going forward.
Delivered 120% revenue, 164% profit growth; 125k unit pace confirmed
EBITDA margin expanded 160bps despite 120% growth; operating leverage working
400+ dealer network across 25+ states; distribution moat vs direct-selling competitors
Market tailwind: 50% EV market CAGR, only 17% penetration, room for 10x growth
Working capital negative in H1; borrowings up 80% to ₹44.8 Cr; debt/equity rising
R&D capex 1–2% EBITDA hit ahead; 2–3 year tech development horizon (motors, batteries)
High-speed market entry faces competition (Ather, Hero, Bajaj); margins uncertain
Commodity inflation pass-through (ASP +10%); vulnerable to price wars if demand softens
Market share timeline extended from 2027–28 to 2030; slower pace than prior guidance
Working capital drain + rising debt
HighOCF negative in H1, borrowings ₹44.8 Cr (up from ~₹25 Cr), debt/equity 0.31x rising. If H2 doesn't absorb inventory buildup and new plants don't ramp to 70+ percent utilization, cash burn continues. Capex squeeze and demand shock could force asset sales or equity dilution.
R&D execution on motors/batteries (2–3 year horizon)
High₹168 Cr capex over 2–3 years to build proprietary motors and batteries. If timeline slips, tech underperforms vs. imported benchmarks, or cost/margin benefits don't materialize, ROI questioned and capex becomes sunk cost. Management says 1–2% EBITDA hit, but raises massive fund — actual impact may be 3–4% if phased quickly.
Commodity inflation pass-through break
MediumASP rose ₹45k → ₹48–50k (+10%) due to raw material/metal inflation. EV demand offset pricing so far, but if demand cools and competitors (esp. newer entrants) undercut on price, margin compression happens fast. ₹1,000 Cr borrowing limit approval suggests management prepared for downside scenario.
High-speed market entry execution
Medium2–3 high-speed SKU launches in 1–2 years. Market already has Ather (market leader), Hero Electric, Bajaj Chetak (legacy player), Konarc (startup). Zelio targeting <₹1 lakh (undercutting) but margin recovery depends on battery tech differentiation (2–3 years away). If launches slip or tech doesn't deliver, revenue mix stays low-speed (lower margin).
Dealer expansion pause creates competitive vacuum
LowPaused at 400–450 vs. 550 target due to demand-supply constraint (good problem). But if competitors (Ather, Hero) expand faster, market share gains slip. Plan to resume H2 mitigates, but watch for dealer churn in underserved regions.
Tariff dispute (₹6.72 Cr custom duty notice)
LowShow-cause notice unpaid, management fighting appeal. Management confident of win (industry-wide issue), but overhang remains. If lost, one-time charge to PAT; if won, reversal upside.
The market's view: Price at ₹1,288, up +19.5% from SMA20 (₹1,078), +97% from SMA200 (₹652), but -5.8% from all-time high of ₹1,367. RSI 76.4 (overbought) — warning sign. Volume is increasing, but on a pullback from the peak, not on the rally itself. This is the signal: momentum is rolling over. FII ownership collapsed from 3.42% (Q2 FY26) to 0.01% (Q2 FY27) — a -3.41 percentage-point exit. DII flat at 2.13%, promoters stable at 72.77%. The divergence is stark: retail and promoters bought the narrative (small base catching up, margins holding), but foreign institutions are selling into the beat quarter. That's a red flag. When FII exits on strong fundamentals, they're pricing in risks the headline doesn't reflect — in this case, the capex/WC headwinds and 2–3 year tech development horizon.
1 · H2 FY27 capex payoff and working capital stabilization
Coimbatore plant (commissioned Q2, at 30% utilization) and Patan ramp must reach 70–80% utilization to absorb capex. Diwali season (Oct–Nov) is seasonal strength; watch if H2 revenue absorbs inventory buildup and OCF turns positive. This is the linchpin for 75–80% FY27 guidance to hold.
2 · High-speed SKU launches (1–2 years) and battery R&D progress
Management targeting 2–3 high-speed models in next 1–2 years. Watch for tech partnerships, design wins, prototype timelines. Battery R&D 2–3 year horizon is long; any miss pushes profitability timelines and raises cost/margin questions.
3 · Dealer network expansion resume (Q3 FY27 onwards)
Currently paused at 400–450. Plan to resume once capex eases in H2. Watch for dealer adds and regional penetration (especially North and East). If expansion accelerates, it confirms demand confidence and reduces geographic concentration risk.
4 · Market share and competitive positioning (ongoing)
At 8–9% share, Zelio is market leader in low-speed, but unorganized market is fragmented. Watch for new entrant pricing and market share trends. If Zelio reaches 15%+ share in next 2 years, 25% by 2030 becomes credible; if stuck at 8–9%, timeline extension signals caution.
Zelio delivered an exceptional quarter on operational execution: 120% growth, 164% profit growth, every target on pace, margins holding. The business is real. But the valuation at all-time high of ₹1,367 and the balance sheet burning working capital and committing ₹168 crore to 2–3 year R&D are two different stories. The stock has priced in the growth narrative; it hasn't priced in the capex year ahead or the working capital drain. FII exit (-3.41pp) during a beat quarter is the market's own verdict: growth is real, but near-term headwinds outweigh. The number to track from here is operating cash flow — if it stays negative or only modestly positive in H2 FY27, the capex thesis and working capital burden become material concerns. For now, hold and wait for capex payoff.
Informational and educational content only. Not investment advice.